Iyikesici, M. S. Et Al. 2016. Long-Term Outcomes of the Treatment of Unresectable (StageIII-IV) Ductal Pancreatic Adenocarcinoma Using Metabolically Supported Chemotherapy (MSCT): A Retrospective Study. JOURNAL OF THE PANCREAS , vol.17 , 36-41.

Iyikesici, M. S. , Slocum, A., Turkmen, E., Akdemir, O., Slocum, A. K. , Ipek, T., ... Eyuboglu, E.(2016). Long-Term Outcomes of the Treatment of Unresectable (StageIII-IV) Ductal Pancreatic Adenocarcinoma Using Metabolically Supported Chemotherapy (MSCT): A Retrospective Study. JOURNAL OF THE PANCREAS , vol.17, 36-41.

Iyikesici, Mehmet Et Al. "Long-Term Outcomes of the Treatment of Unresectable (StageIII-IV) Ductal Pancreatic Adenocarcinoma Using Metabolically Supported Chemotherapy (MSCT): A Retrospective Study," JOURNAL OF THE PANCREAS , vol.17, 36-41, 2016

Iyikesici, Mehmet S. Et Al. "Long-Term Outcomes of the Treatment of Unresectable (StageIII-IV) Ductal Pancreatic Adenocarcinoma Using Metabolically Supported Chemotherapy (MSCT): A Retrospective Study." JOURNAL OF THE PANCREAS , vol.17, pp.36-41, 2016

Iyikesici, M. S. Et Al. (2016) . "Long-Term Outcomes of the Treatment of Unresectable (StageIII-IV) Ductal Pancreatic Adenocarcinoma Using Metabolically Supported Chemotherapy (MSCT): A Retrospective Study." JOURNAL OF THE PANCREAS , vol.17, pp.36-41.

@article{article, author={Mehmet Salih Iyikesici Et Al. }, title={Long-Term Outcomes of the Treatment of Unresectable (StageIII-IV) Ductal Pancreatic Adenocarcinoma Using Metabolically Supported Chemotherapy (MSCT): A Retrospective Study}, journal={JOURNAL OF THE PANCREAS}, year=2016, pages={36-41} }